M28 Capital Management LP Long-Term Concentrated

Location: Stamford, CT

CIK: 0001807489 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 13, 2025

Total Value: $68.01M (100.0% shares, 0.0% debt)

Holdings (9)

WVE WAVE LIFE SCIENCES LTD 61.0%

Value $41.46M Shares 5,664,548 Est. Cost $3.40 Unrealized +138.1%

IVVD INVIVYD INC 15.0%

Value $10.17M Shares 9,248,250 Est. Cost $17.64 Unrealized -95.0%

TGTX TG THERAPEUTICS INC 8.6%

Value $5.838M Shares 161,600 Est. Cost $15.49 Unrealized +112.6%

GUTS FRACTYL HEALTH INC 4.3%

Value $2.951M Shares 1,856,117 Est. Cost $8.42 Unrealized -84.6%

ARWR ARROWHEAD PHARMACEUTICALS IN 3.4%

Value $2.325M Shares 67,400 Est. Cost $33.13 Unrealized -33.6%

PRQR PROQR THRAPEUTICS N V 3.2%

Value $2.172M Shares 1,019,498 Est. Cost $2.38 Unrealized -8.2%

RCKT ROCKET PHARMACEUTICALS INC 1.8%

Value $1.257M Shares 385,680 Est. Cost $23.75 Unrealized -86.7%

SLN SILENCE THERAPEUTICS PLC 1.4%

Value $961K Shares 185,100 Est. Cost $9.41 Unrealized —

CRIS CURIS INC 1.3%

Value $865K Shares 521,059 Est. Cost $11.24 Unrealized -84.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
WVE	WAVE LIFE SCIENCES LTD	5,664,548	$41.46M	61.0%	$3.40	+138.1%	SHS	Y95308105
IVVD	INVIVYD INC	9,248,250	$10.17M	15.0%	$17.64	-95.0%	COM	00534A102
TGTX	TG THERAPEUTICS INC	161,600	$5.838M	8.6%	$15.49	+112.6%	COM	88322Q108
GUTS	FRACTYL HEALTH INC	1,856,117	$2.951M	4.3%	$8.42	-84.6%	COM	35168W103
ARWR	ARROWHEAD PHARMACEUTICALS IN	67,400	$2.325M	3.4%	$33.13	-33.6%	COM	04280A100
PRQR	PROQR THRAPEUTICS N V	1,019,498	$2.172M	3.2%	$2.38	-8.2%	SHS EURO	N71542109
RCKT	ROCKET PHARMACEUTICALS INC	385,680	$1.257M	1.8%	$23.75	-86.7%	COM	77313F106
SLN	SILENCE THERAPEUTICS PLC	185,100	$961K	1.4%	$9.41	—	ADS	82686Q101
CRIS	CURIS INC	521,059	$865K	1.3%	$11.24	-84.6%	COM	231269309